(Q68631789)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

review article

1 reference

title

Chromatographic analysis of anticancer drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

author name string

U R Tjaden

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

E A de Bruijn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

publication date

1 October 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

volume

531

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

page(s)

235-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

Drug level monitoring: cytostatics

26 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Clinical pharmacokinetics of drugs used in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Inhibition of human tumour clonogenicity by chlorambucil and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Degradation of chlorambucil in aqueous solution—influence of human albumin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Kinetics of chlorambucil hydrolysis using high-pressure liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Chlorambucil: stability of solutions during preparation and storage

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid assay for plasma chlorambucil and phenyl acetic mustard using reversed-phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Studies on the quantitation of chlorambucil in plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of chlorambucil in plasma using reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatography of chlorambucil analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Characterization of glutathione conjugates of chlorambucil by fast atom bombardment and thermospray liquid chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of chlorambucil in plasma by GLC with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

In vitro degradation of L-phenylalanine mustard (L-PAM)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Degradation of melphalan in aqueous solutions--influence of human albumin binding

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Stability of melphalan solutions during preparation and storage.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Measurement of plasma melphalan at therapeutic concentrations using isocratic high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic analysis of melphalan in plasma, brain and peripheral tissue by o-phthalaldehyde derivatization and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Modified extraction and chromatography for the measurement of plasma melphalan by ion-pair high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitative determination of melphalan in plasma by liquid chromatography after derivatization with N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Solvent-sample interactions in thermospray mass spectrometry of antineoplastic nitrogen mustards

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Degradation of busulfan in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Binding of busulfan to plasma proteins and blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Measurement of busulfan in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of busulfan in plasma by GC-MS with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas chromatographic determination of busulfan in plasma with electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of busulfan in human plasma by gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of busulfan in human plasma by gas chromatography with electron-capture detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-Performance Liquid Chromatographic Analysis of Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High‐Performance Liquid Chromatographic Assay of Cyclophosphamide in Raw Material and Parenteral Dosage Forms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic measurement of cyclophosphamide in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of cyclophosphamide in whole blood and plasma by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid method for the determination of ifosfamide and cyclophosphamide in plasma by high-performance liquid chromatography with solid-phase extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Liquid chromatographic determination of cyclophosphamide enantiomers in plasma by precolumn chiral derivatization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of the underivatized antineoplastic drugs cyclophosphamide and 5-fluorouracil and some of their metabolites by capillary gas chromatography combined with electron-capture and nitrogen-phosphorus selective detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Monitoring the behaviour of 4-ketocyclophosphamide versus cyclophosphamide during capillary gas chromatography by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Combined thin-layer chromatography—photography—densitometry for the quantitation of cyclophosphamide and its four principal urinary metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Electron-capture--gas chromatographic analysis of ifosfamide in human plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid gas chromatographic determination of ifosfamide in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A simple quantitative HPLC assay for ifosfamide in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of ifosfamide in plasma by gas chromatography with nitrogen detector

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Plasma cyclophosphamide assay by selective ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Improved analysis of cyclophosphamide by capillary gas chromatography with thermionic (nitrogen-phosphorus) specific detection and silica sample purification

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Chromatographic resolutions. XIV. Optical resolution of the racemic anticancer drug ifosfamide and other chiral oxazaphosphorines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatography of the anti-tumour agent triethylenethiophosphoramide and its metabolite triethylenephosphoramide with sodium sulphide, taurine and o-phthalaldehyde as pre-column fluorescent derivatization reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas chromatographic assay of triethylenethiophosphoramide in serum and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas-liquid chromatographic analysis of N,N',N''-triethylene thiophosphoramide and N,N',N''-triethylene phosphoramide in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of 1,3-bis(2-chloroethyl)-1-nitrosourea in plasma using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A high pressure liquid chromatographic procedure for monitoring 1-(2-chloroethyl)-3-(4-trans-methylcyclohexyl)-1-nitrosourea levels in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of lipophilic chloroethylnitrosourea cancer chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis for nitrosourea antitumor agents by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Platinum Compounds: a New Class of Potent Antitumour Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A method for determining cis-dichlorodiammineplatinum(II) in plasma and urine by high performance liquid chromatography with direct ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Post-column reaction detector for platinum(II) antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Evaluation of reductive amperometric detection in the liquid chromatographic determination of antineoplastic platinum complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of cis-diamminedichloroplatinum(II) in human plasma using ion-pair chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Trace analysis for cis-platinum anti-cancer drugs via LCEC.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Comparison of mercury- and glassy carbon-based electrochemical detection systems for the determination of cisplatin following high-performance liquid chromatographic separation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of ethylenediamineplatinum(II) malonate in infusion fluids, human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reductive activation of mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Mechanism of monofunctional and bifunctional alkylation of DNA by mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Regeneration characteristics of mitomycin C-dextran conjugate in relation to its activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Absorption of doxorubicin-hydrochloride and mitomycin-C after instillation into noninfected and infected bladders of dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Absorption characteristics of the lipophilic prodrug of mitomycin C from injected liposomes or an emulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of mitomycin C in dogs: application of a high-performance liquid chromatographic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Clinical pharmacokinetics of high-dose mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of mitomycin C in plasma, serum and urine by high-performance liquid chromatography with ultra-violet and electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of mitomycin C in rabbit and human

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Liquid chromatographic determination of mitomycin C in human plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Improved regional selectivity of hepatic arterial mitomycin by starch microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase high-performance liquid chromatographic determination of mitomycin C in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The stability and antitumor activity of recycled (intravesical) mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic assay of mitomycin in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Chromatographic studies of mitomycin C degradation in albumin microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Automated analysis of mitomycin C in body fluids by high-performance liquid chromatography with on-line sample pre-treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Phase-system switching as an on-line sample pretreatment in the bioanalysis of mitomycin C using supercritical fluid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Mitomycin C plasma levels after intravesical instillation with and without hyaluronidase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Chemical stability of mitomycin C in culture medium with and without fetal calf serum as determined by high pressure liquid chromatography and mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Use of high-performance liquid chromatography to detect hydroxyl and superoxide radicals generated from mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Detecting mitomycin C in human plasma during intravesical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Behavior and resorption of mitomycin C following multiple intravesical administrations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Experimental systemic toxicology of 4'-epidoxorubicin, a new, less cardiotoxic anthracycline antitumor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Isotachophoretic determination of adriamycin and adriamycinol in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Concomitant adsorption and stability of some anthracycline antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of adriamycin and adriamycinol in micro volumes of rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Extraction and quantification of daunomycin and doxorubicin in tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of 4'-epi-doxorubicin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Aspects of the chemical stability of doxorubicin and seven other anthracyclines in acidic solution

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of carminomycin in human serum by fluorometric high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

New high-performance liquid chromatographic assay for plasma doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Assay of doxorubicin and 4'-epidoxorubicin by reversed-phase ion-pair chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Differential adriamycin distribution to blood components

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of doxorubicin and its metabolite doxorubicinol in rabbits with induced acid and alkaline urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Ultraviolet photoirradiation of daunomycin and DNA daunomycin complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Photolytic Destruction of Adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of Antitumor Antibiotics by High Pressure Liquid Chromatography (HPLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Intraperitoneal infusion of doxorubicin in the treatment of gynecologic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Anthracycline assay by high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High performance liquid chromatographic determination of aclacinomycin A and its related compounds. I. Normal phase HPLC for monitoring fermentation and purification processes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of aclacinomycin A by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Improved high-performance liquid chromatography assay of doxorubicin: detection of circulating aglycones in human plasma and comparison with thin-layer chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Plasma Protein Binding and Urinary Excretion of R- and S-Epimers of an Arylmalonylamino 1-Oxacephem I: In Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Intensely potent morpholinyl anthracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A method for the simultaneous measurement of the new anthracycline derivative 4'-deoxydoxorubicin and its metabolites by reversed phase liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Application of analytical and semi-preparative high-performance liquid chromatography to anthracyclines and bis-anthracycline derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reverse phase high speed liquid chromatography of antibiotics. III. Use of ultra high performance columns and ion-pairing techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Metabolism of 4'-modified analogs of doxorubicin. unique glucuronidation pathway for 4'-epidoxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Time dependency of adriamycin and adriamycinol kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of adriamycin in plasma and urine: comparative study of radioimmunoassay and high-performance liquid chromatography methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of 4'-epidoxorubicin and its 13-dihydro derivative in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A high performance liquid chromatographic method of analysis of 4'-O-tetrahydropyranyladriamycin and their metabolites in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of adriamycin and daunorubicin in urine by high-performance liquid chromatography with laser fluorometric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Qualitative analysis of trimethylsilylated daunosamine and N-alkylated analogs by gas chromatography--mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Cosmomycin D. A new anthracycline antibiotic.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

New anthracycline derivatives from betaclamycin A

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Disposition of 14C-labelled 4'-epidoxorubicin and doxorubicin in the rat. A comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Therapeutic activity of 4-demethoxydauno-rubicin (idarubicin) in adult acute leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Phase II trial with oral idarubicin in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Method for the determination of 4-demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase liquid chromatographic determination of idarubicin and its 13-hydroxy metabolite in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Improved high-performance liquid chromatographic method using loop-column extraction for analysis of idarubicin and idarubicinol in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Radioimmunoassay for mitoxantrone, a new antitumor agent

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for mitozantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase high-performance liquid chromatographic assay for the antineoplastic agent 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl hydrazone) dihydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic assay for mitoxantrone in plasma using electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Direct determination of mitoxantrone and its mono- and dicarboxylic metabolites in plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Mitoxantron determination using high-performance liquid chromatography: Improved sensitivity by loop-column injection for dual-dose pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic determination of mitoxantrone in plasma utilizing non-bonded silica gel for solid-phase isolation to reduce adsorptive losses on glass during sample preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of amsacrine in human nucleated hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid-chromatographic method for the determination of 4'-(9-acridinylamino)methanesulfon-m-anisidide in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of amsacrine in patients receiving combined chemotherapy for treatment of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

1 reference

7 January 2021

Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Photolability of bleomycin and its complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase paired-ion high-performance liquid chromatographic method for the separation and quantification of multiple bleomycin congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Modification of a new high-performance liquid chromatographic method for bleomycin to separate epi-, iso-, desamido-, and unmodified analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance paired-ion liquid chromatographic determination of bleomycin A2 in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Integrated biological-physicochemical system for the identification of antitumor compounds in fermentation broths

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of methotrexate by isotachophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of methotrexate and its major metabolite, 7-hydroxymethotrexate, using capillary zone electrophoresis and laser-induced fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid high-pressure liquid chromatographic determination of methotrexate and its metabolites 7-hydroxymethotrexate and 2,4-diamino-N(10)-methylpteroic acid in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Separation and identification of methotrexate and its metabolites, 7-hydroxymethotrexate and polyglutamates, in human tissues by reversed-phase high-performance liquid chromatography coupled with radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Detection by high-performance liquid chromatography of methotrexate and its metabolites in tumor tissue from osteosarcoma patients treated with high-dose methotrexate/leucovorin rescue

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of methotrexate in untreated body fluids by micellar liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Micellar high-performance liquid chromatographic determination of folylpolyglutamate hydrolase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A sensitive high-performance liquid chromatographic-fluorometric assay for dihydrofolate reductase in adult rat brain, using 7,8-dihydrobiopterin as substrate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Radioimmunoassays of 7-hydroxymethotrexate and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Fluorometric high-performance liquid chromatographic analysis of 10-deazaaminopterin, 10-ethyl-10-deazaaminopterin, and known metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of the antineoplastic agent methotrexate in body fluids by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Separation of methotrexate analogs containing terminal lysine or ornithine and their dansyl derivatives by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of methotrexate polyglutamate derivatives in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid and simple assay for the measurement of methotrexate in serum, urine and red blood cells by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Concurrent analysis of methotrexate, trimethoprim, sulphamethoxazole and their major metabolites in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid and inexpensive enzyme inhibition assay of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Fluorouracil: biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Clinical pharmacology of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Simultaneous determination of tegafur and 5-fluorouracil in serum by GLC using nitrogen-sensitive detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitative analysis of 5-fluorouracil and 5,6-dihydrofluorouracil in plasma by gas chromatography mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase ion-pair high-performance liquid chromatographic assay of 5-fluorouracil, 5′-deoxy-5-fluorouridine, their nucleosides, mono-, di-, and triphosphate nucleotides with a mixture of quaternary ammonium ions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A rapid high-performance liquid chromatographic method for quantitation of 5-fluorouracil in plasma after continuous intravenous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Comparison of the reversed-phase high-performance liquid chromatographic separations of fluoropyrimidines, pyrimidines, and purines

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Separation of 5-fluorouracil and uracil by ion-pair reversed-phase high-performance liquid chromatography on a column with porous polymeric packing

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Simultaneous analysis of 5′-deoxy-5-fluororidine and 5-fluorouracil in plasma by analytical isotachophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of a novel fluoropyrimidine, 5'-deoxy-5-fluorouridine, in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Fluorescence determination of 5-fluorouracil and 1-(tetrahydro-2-furanyl)-5-fluorouracil in blood serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of 5'-deoxy-5-fluorouridine and 5-fluorouracil in human plasma and urine by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Gas-liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Highly sensitive determination of 5-fluorouracil in human plasma by capillary gas chromatography and negative ion chemical ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of 5-fluorouridine diphosphate glucose as a metabolite of 5-fluorouracil in mouse T-lymphoma (S-49) cells using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic analysis of fluoropyrimidine nucleosides and fluorouracil in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of 5-fluoro-2'-deoxycytidine and 5-trifluoromethyl-2'-deoxycytidine and their related antimetabolites by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

5-fluorouracil metabolism monitored in vivo by 19F NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Direct 19F NMR spectroscopic observation of 5-fluorouracil metabolism in the isolated perfused mouse liver model

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

In vivo 19F NMR spectroscopy of the antimetabolite 5-fluorouracil and its analogues. An assessment of drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The stability of 5,6-dihydrofluorouracil in plasma and the consequences for its analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of cytosine arabinoside in human plasma by gas chromatography with a nitrogen-sensitive detector and by gas chromatography--mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Studies of hydroxyurea administered by continuous infusion: toxicity, pharmacokinetics, and cell synchronization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic analysis of hydroxyurea in pharmaceutical formulations and in the bulk

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Inhibition of mannose incorporation into glycoproteins and dolichol-linked intermediates of Sarcoma 180 cells by 6-methylmercaptopurine ribonucleoside

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic determination of plasma 6-mercaptopurine in clinically relevant concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of 6-mercaptopurine in human plasma with a high-performance liquid chromatographic method including post-column derivatization and fluorimetric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Simultaneous determination of azathioprine and 6-mercaptopurine in serum by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: a selective and novel procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Reversed-phase high-performance liquid chromatography analysis of 6-thioguanine applicable to pharmacologic studies in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Extractive alkylation of 6-mercaptopurine and determination in plasma by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A rapid and sensitive high-performance liquid chromatographic assay for 6-mercaptopurine metabolites in red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Sensitive high-performance liquid chromatographic determination of 6-mercaptopurine, 6-thioguanine, 6-mercaptopurine riboside and 6-thioguanosine in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

The use of xanthine oxidase for a specific and sensitive fluorimetric determination of 6-mercaptopurine in serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A novel method for the quantitation of 6-mercaptopurine in human plasma using high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Assay of 6-mercaptopurine in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of 6-mercaptopurine in serum or plasma using high performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Sensitive and specific high-performance liquid chromatographic assay for 6-thiouric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A clinically useful ion-pairing high-performance liquid chromatographic assay for the monophosphate metabolites of thioguanine and mercaptopurine in human neoplastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

HPLC analysis of 6-mercaptopurine and metabolites in extracellular body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid method for evaluating compliance of 6-mercaptopurine therapy in children with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatographic determination of vinca-alkaloids in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of vinblastine in MO4 mouse fibrosarcoma cells by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Liquid chromatographic isolation of vincristine and vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of vinca alkaloids in plasma and urine using ion-exchange chromatography on silica gel and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

High-performance liquid chromatography determination of 4'-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene beta-D-glucopyranoside) (VP 16-213) in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Automated reversed-phase chromatographic analysis of etoposide and teniposide in plasma by using on-line surfactant-mediated sample clean-up and column-switching

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Glycosaminoglycans and proteoglycans induce gap junction expression and restore transcription of tissue-specific mRNAs in primary liver cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

1 reference

7 January 2021

Sixth NCI-EORTC symposium on new drugs in cancer therapy. Amsterdam, March 7-10 1989. Abstracts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of suramin in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of suramin plasma levels by ion-pair high-performance liquid chromatography under isocratic conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Rapid high-performance liquid chromatographic determination of suramin in plasma of patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Bioanalysis of suramin in human plasma by ion-pair high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Assay of 1-hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Quantitative gas chromatographic determination of tamoxifen citrate in pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Simultaneous determination of tamoxifen citrate and its E isomer impurity in bulk drug and tablets by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of tamoxifen and 4-hydroxytamoxifen levels in immature rat uterine cytoplasm and KCl-nuclear extracts by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

Analysis of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen levels in cytosol and KCl-nuclear extracts of breast tumours from tamoxifen treated patients by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2800%2982286-0

7 January 2021

10.1016/S0378-4347(00)82286-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2258419%20AND%20SRC:MED&resulttype=core&format=json

26 September 2019

1 reference